Sign in

CIK 0001842295 · Non-accelerated filer<br>Emerging growth company

Maze Therapeutics, Inc.

Sign in to watch
Ticker
MAZE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6508505070
Business address
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. S-3ASR Offering Registration Statement
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. EFFECT Other Notice of Effectiveness
  16. S-1MEF Other S-1MEF
  17. CERT Other Certification
  18. 8-A12B Other Registration of Securities
  19. DRS/A Other Draft Registration Statement
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 2 of 3 · 47 filings